Pei-Jer CHEN
Hepatitis Research Center, National Taiwan University Hospital
Professor Chen was appointed Director of the Hepatitis Research Center at the National Taiwan University Hospital in Taipei in 2001-2003, and now the faculty for Graduate Institute of Clinical Medicine, National Taiwan University. He was the President of Taiwan Association for Study of the Liver (TASL) from 2012 to 2013. He served as the President of Taiwan Society of Virology from 2016-2018.
His research interests cover on the molecular virology and immunology of hepatitis viruses, and the genetic and genomic study of hepatocellular carcinoma. Professor Chen’s clinical research include the natural history of chronic viral hepatitis and hepatocellular carcinoma, and also explores and conducts new therapies and trials for both diseases. He has published over 630 articles in the areas of hepatitis and hepatocellular carcinoma.
He served in the Editorial Board of Gastroenterology between 2017-2019. He was a was a member of the editorial board of the journal Hepatology from 2001 to 2006, 2010-2011, and 2019-2021. In 2000, Professor Chen was awarded the International Research Scholar in Infectious Diseases by the Howard Hughes Medical Institute for a period of five years. He has been elected into Academia Sinica in year 2006, and become the TAWS member in year 2011.
His research interests cover on the molecular virology and immunology of hepatitis viruses, and the genetic and genomic study of hepatocellular carcinoma. Professor Chen’s clinical research include the natural history of chronic viral hepatitis and hepatocellular carcinoma, and also explores and conducts new therapies and trials for both diseases. He has published over 630 articles in the areas of hepatitis and hepatocellular carcinoma.
He served in the Editorial Board of Gastroenterology between 2017-2019. He was a was a member of the editorial board of the journal Hepatology from 2001 to 2006, 2010-2011, and 2019-2021. In 2000, Professor Chen was awarded the International Research Scholar in Infectious Diseases by the Howard Hughes Medical Institute for a period of five years. He has been elected into Academia Sinica in year 2006, and become the TAWS member in year 2011.
The lecture video：0
Abstract：1
43
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2022-09-17 | 14:05-14:25 | 2022-09-17,14:05-14:25 | Meeting Room 1 |
Concurrent Session 4 - Management of Viral Hepatitis II |
Speaker | A novel, long acting, interferon (Ropeginterferon) for chronic viral hepatitis B or D |
| 2022-09-18 | 15:30-17:00 | 2022-09-18,15:30-17:00 | Meeting Room 1 |
State-of-the-art Session 5 |
Moderator |